Authorisation for use
The MHRA’s conditions of authorisation and the information for healthcare professionals and recipients outlines the framework through which the vaccine can be used.
Storing vaccine appropriately
Effective process control is essential to ensure that vaccines are stored correctly and expiry dates and times are allocated.
Up to date information on storage requirements may be found in the product specific documentation.
Preparing vaccine
Using COVID-19 Vaccine AstraZeneca in Community Pharmacy
Administration
Administration requires diligent process control to ensure the vaccine is safe and effective at the point of use.
Use in relation to prior allergy
Prior to administration, prior allergy status should be checked.
Advising individuals with allergies on their suitability for COVID-19 Vaccine AstraZeneca
Process flow for vaccination session
A diagram giving an overview of the process during a vaccination session is attached below.
SOPs, work instructions and checklists to adapt
Relevant Standard Operating Procedures, work instructions and checklists are available below. These may be adapted by Superintendent Pharmacists for use in Community Pharmacy settings.
Receiving and storing Vaxzevria Vaccine at PCN designated sites
Preparing the Vaxzevria Vaccine at PCN designated sites and end user locations
Stocktaking and reconciliation of the Vaxzevria Vaccine at PCN designated sites
Disposing of the Vaxzevria Vaccine at PCN designated sites
Dealing with spillages and breakages of the Vaxzevria Vaccine at PCN designated sites
Transporting the Vaxzevria Vaccine from PCN designated sites to end user locations, patients’ homes and within the PCN Grouping
Change history
- Simplification of storage requirements. Removal of reference to additional doses within vials. All other current content is still accurate.
- The current content is still accurate
- Removal of "temporary" in conditions of authorisation. All other current content is still accurate.
- Published